These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18381)

  • 41. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ; Dubick MA; Wade CE; Holcomb JB
    Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED; Shainoff JR; Graham RC; Ratnoff OD
    J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S; Bark N; Wang H; Svensson J; Blombäck M
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-enzymatic glucosylation of fibrinogen.
    McVerry BA; Thorpe S; Joe F; Gaffney P; Huehns ER
    Haemostasis; 1981; 10(5):261-70. PubMed ID: 7274778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New method to prepare autologous fibrin glue on demand.
    Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
    Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Identification and preparation of high-molecular derivatives of fibrinogen from human plasma by means of PAA-gel electrophoresis and agarose-gel chromatography].
    von Hugo R; Graeff H
    Thromb Diath Haemorrh Suppl; 1973; 55():325-37. PubMed ID: 4216114
    [No Abstract]   [Full Text] [Related]  

  • 50. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FIBRINOGEN CLOTTING AND FIBRINO-PEPTIDE FORMATION BY STAPHYLOCOAGULASE AND THE COAGULASE-REACTING FACTOR.
    DRUMMOND MC; TAGER M
    J Bacteriol; 1963 Mar; 85(3):628-35. PubMed ID: 14042942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fibrinogen "Hannover", a further abnormal fibrinogen].
    Barthels M; Sandvoss G
    Blut; 1977 Feb; 34(2):99-106. PubMed ID: 836970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and antithrombotic activity identification of Perinereis aibuhitensis extract: a high temperature and wide pH range stable biological agent.
    Li Y; Li J; Liu T; Wang Y; Zhou Z; Cheng F; Feng C; Cheng X; Liu H; Chen X
    Food Funct; 2017 Oct; 8(10):3533-3541. PubMed ID: 28875196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering.
    Haisch A; Loch A; David J; Pruss A; Hansen R; Sittinger M
    Med Biol Eng Comput; 2000 Nov; 38(6):686-9. PubMed ID: 11217888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the properties of fibrin monomer prepared from fibrin clot with acetic acid.
    Pozdnjakova TM; Musjalkovskaja AA; Ugarova TP; Protvin DD; Kotsjuruba VN
    Thromb Res; 1979; 16(1-2):283-8. PubMed ID: 505426
    [No Abstract]   [Full Text] [Related]  

  • 57. FIBRIN CLOT FORMATION AND THE RELEASE OF CARBOHYDRATE.
    CHANDRASEKHAR N; LAKI K
    Biochim Biophys Acta; 1964 Nov; 93():392-7. PubMed ID: 14251318
    [No Abstract]   [Full Text] [Related]  

  • 58. Disulfide bond cleavage of human fibrinogen by cis-diamminedichloroplatinum(II).
    Ohta N; Yotsuyanagi T; Ikeda K
    J Pharmacobiodyn; 1992 Nov; 15(11):611-5. PubMed ID: 1289495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Light and heavy fractions of fragment D: preparation and examination of fibrin-binding properties.
    Belitser VA; Pozdnjakova TM; Ugarova TP
    Thromb Res; 1980 Sep; 19(6):807-14. PubMed ID: 7466749
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of soluble fibrin in plasma using fibrinogen sepharose columns.
    Lund PK; Brosstad F; Kierulf P
    Thromb Res; 1977 Dec; 11(6):907-12. PubMed ID: 601758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.